Infanrix DTPa-IPV+Hib

Infanrix DTPa-IPV+Hib is a medicine authorised by Swissmedic under authorisation number 619. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 September 1998 and the authorisation is valid without a time limit. ATC code J07CA06 places the medicine in the group Vaccines.

  • Dispensing category B
  • Authorisation number 619
  • ATC J07CA06
  • Vaccines
Authorisation data
Authorisation number619
NameInfanrix DTPa-IPV+Hib
Full nameInfanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension
Authorisation holderGlaxoSmithKline AG
Medicinal product codeVaccines
Dispensing categoryB · Prescription only
ATC codeJ07CA06
First authorisation29 September 1998
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer InjektionssuspensionB29 September 1998

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
31Fertigspritze(n)J07CA0608.08.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Infanrix DTPa-IPV+Hib authorised in Switzerland?

Yes. Infanrix DTPa-IPV+Hib is authorised by Swissmedic under authorisation number 619, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Infanrix DTPa-IPV+Hib have?

Infanrix DTPa-IPV+Hib is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Infanrix DTPa-IPV+Hib?

The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com